Conversations with Innovators: Joseph Connors, MD, on Targeted Therapy for Hodgkin Lymphoma

Cellular and targeted therapies for Hodgkin lymphomaПодробнее

Joseph M. Connors, MD: Optimizing Therapy, Minimizing Toxicity in Hodgkin LymphomaПодробнее

Blood Review Series – Update on Hodgkin LymphomaПодробнее

17. Targeted therapy for non-Hodgkin lymphoma – Dr Cathy BurtonПодробнее

Targeted therapy for cancer. | Amjad Husain | TEDxMansaroverParkПодробнее

Effective Therapies in Classical Hodgkin LymphomaПодробнее

What is Targeted Therapy for Treating Non-Hodgkin Lymphomas? (From Chapter 3)Подробнее

How I Treat Hodgkin Lymphoma - Joseph Connors, MDПодробнее

Improving Targeted Therapies for Patients with Previously Untreated Advanced Classic Hodgkin LymphomПодробнее

CD47-targeting antibody: targeting the source of non-Hodgkin lymphomaПодробнее

The addition of immunotherapy to the front-line treatment of AS Hodgkin lymphomaПодробнее

Debate: Hodgkin lymphoma patient who remains PET+ at the end of chemotherapy - Radiation therapyПодробнее

The importance of risk-adapted therapies in Hodgkin lymphomaПодробнее

Novel Treatments for Lymphoma: Focus on Targeted TherapiesПодробнее

Case Review: Newly Diagnosed Stage IV Hodgkin LymphomaПодробнее

The potential of targeted therapy in DLBCL: open questionsПодробнее

Dr. Moskowitz on PET-Adapted Therapy in Advanced Hodgkin LymphomaПодробнее

Using PET to determine treatment response in Hodgkin lymphomaПодробнее